RDD Europe 2011 Workshop 4 May 2011

Size: px
Start display at page:

Download "RDD Europe 2011 Workshop 4 May 2011"

Transcription

1 RDD Europe 2011 Workshop 4 May 2011 This file represents the slides presented on May 4, 2011 by 3M Drug Delivery Systems at the RDD Europe 2011 Conference in Berlin, Germany. Slides have been modified to support electronic distribution in pdf form after the Conference. RDD Europe M DPI Workshop rev 3 FINAL PRESENTED SLIDES modified for post Workshop distribution.pptx

2 DPI Products: Design for Manufacturability and Scale-up (DFMSU) This Workshop will discuss considerations to ensure success during the various phases of development of dry powder inhaler (DPI) products. Topics will include: device design and development, the importance of a disciplined design control process, process design and development, unit cost estimating and the importance of an overall development map. Participants will leave with a deepened appreciation of the role that DFMSU plays in the development of DPI products. 2

3 Workshop Presenters Rich Sitz Stephen Stein 3

4 Workshop Outline Who is 3M Drug Delivery Systems? Why DFMSU? Design Controls DFMSU in Early & Late Stage Development Unit Cost Estimating Wrap Up/Discussion 4

5 Who is 3M Drug Delivery Systems? A Global Leader in Inhalation Drug Delivery 3M Drug Delivery Systems Division Leverages 3M Technologies and Manufacturing Expertise Partner API Over 50 years experience developing and manufacturing inhalation products 5

6 3M Dry Powder Inhaler Platforms 3M Taper Can contain up to 120 premetered doses. Uses active dispersion of drug to increase delivery efficiency. Delivers neat drug (no carrier powder required). When compared to in-vitro results from Advair Diskus, would deliver 50 to 70 percent less drug to a patient while delivering the same therapeutic dose to the lung (as defined by fine particle dose). 3M Conix Is available in single-dose disposable, single-dose reloadable, and multi-dose configurations. Efficiently leverages a patient's inspiratory flow to deagglomerate the drug powder. Has been used in a recently concluded Phase I clinical study, with excellent results. 6

7 Workshop Outline Who is 3M Drug Delivery Systems? Why DFMSU? Design Controls DFMSU in Early & Late Stage Development Unit Cost Estimating Wrap Up/Discussion 7

8 Why DFMSU? What could possibly go wrong during product development? Quality: poor performance. Cost: too expensive (development cost, capital equipment cost, product cost) Time: takes longer than planned. DFM is part of a disciplined process to help you meet your quality, cost and time goals. 8

9 Why DFMSU? high DFM is part of a robust development process to insure you can live long-term with today s decisions. low Development timeline 9

10 Workshop Outline Who is 3M Drug Delivery Systems? Why DFMSU? Design Controls DFMSU in Early & Late Stage Development Unit Cost Estimating Wrap Up 10

11 What are Design Controls? A formal methodology for management and documentation of product development projects Required for development of medical devices and combination products (drug + device) 21 CFR 820, ISO 9001/ISO 13485, ICH Q8 Key components: Design and Development Plan Design History File Design Requirements Specifications Device Specification (Design Input) Design Reviews Design Verification Design Validation Risk Management Process 11

12 Workshop Outline Who is 3M Drug Delivery Systems? Why DFMSU? Design Controls DFMSU in Early & Late Stage Development Unit Cost Estimating Wrap Up 12

13 Background Information Diskus/Accuhaler DPI Design Diskus/Accuhaler DPI developed by GSK Used in multiple drug products (including Advair) 60 dose blister strip ~12 mg of formulation (ordered blend using lactose monohydrate) Blister peeled prior to dosing to expose formulation Serevent, Diskus and Advair are registered to GlaxoSmithKline 13

14 Background Information - Taper DPI Design Microstructured carrier tape (MCT): MCT contains microstructure cavities filled with API Lactose carrier not required, can use neat drug Dose range of to 2 mg API per dose (fine particle doses between and 0.78 mg) Upon inhalation, spring impactor strikes tape and aerosolizes drug Multi-dose device: Up to 120 pre-metered doses with integrated moisture protection Patient-friendly features: Dose counter and dose ready-indicator Visual and audible feedback of dose delivery Simple, 3-step, breath-actuated delivery (open-inhaleclose) with a compact pocket-sized device 14 14

15 Applying DFMSU During Early Stages of Technology Development 15

16 Early Device Design Prototype Development Types of Prototypes: Industrial design prototypes (aka form study prototypes ) Subassembly breadboards Functional Prototypes ( Looks Like/Works Like models) Prototype Fabrication Techniques: Hand fabricating CNC machining Stereolithography (SLA) Rapid injection mold tooling Computer simulations (e.g. CFD, FEA, etc.) Many other techniques available 16

17 Process Development During Early Development Don t forget the processes! Many processes become locked in based on early device design decisions! Map out 20,000 foot view of manufacturing process: Sub-assembly strategy Facilities requirements Failure mode analysis of processes: Identify high priority processes Evaluate feasibility of high priority processes Focus early (limited) resources on these processes Preliminary assessment of process scaleability 17

18 20,000 Foot View of Taper Sub-Assembly Strategy MCT Moisture Control Chamber Subassembly Lower Housing Subassembly Final Assembly Labeling and Packaging MCT Moisture Control Chamber Subassembly Highest value subassembly Keep at 3M site to protect IP Lower Housing Subassembly Standard molded parts and routine pick-&-place assembly Provides manufacturing location flexibility 18

19 Taper DPI Process Development MCT Extrusion Dose determined by number and volume of dimples Control of dimple dimensions in MCT is crucial to controlling dose delivery MCT formed using extrusion embossing process 3M leverages this type of microreplication for many applications Nominally 230 mcg/dose MCT Nominally 1000 mcg/dose MCT Outcome: Demonstration of commercial capability. 19

20 Taper DPI Process Development MCT Coating Proprietary asynchronous roller coating method used to coat MCT High through-put process 1000 doses per minute Outcome: Demonstration of commercial capability. 20

21 Applying DFMSU During Later Stages of Technology Development 21

22 Taper DPI Process Development Threading of MCT through Small Opening Supply of MCT is stored on a spool in a moisture control chamber Chamber maintains RH at desired level Two concepts: (1) Window ; (2) 'Slot' 'Window' preferred for moisture protection; needed to demonstrate ability to thread MCT through window Worked with expert automation vendor to demonstrate PoC Ensure design provides acceptable performance & manufacturability Window Design Slot Design Outcome: Demonstration of high speed process. 22

23 Taper DPI Process Development Foil Sealing of Moisture Chamber Early development used conductive sealing Induction sealing highly desired for automation Unusual seal shape Constraints on foil selection PoC work initiated Utilized external experts Demonstrated acceptable seal performance and cycle times Reduced capital expenditure Outcome: Demonstration of high speed mfg process. 23

24 Design for Injection Molding 24

25 Design for Injection Molding Objectives Minimize cost of molded parts and mold tools Maximize molding reliability (complete shots, no flash, etc.) Utilize industry experts Critically review of every part for moldability Determine Type of Tooling Needed Capacity requirements Regulatory strategy 25

26 Design for Injection Molding No draft Part Attributes that Simplify Molding: Avoid undercuts & secondary tool actions Avoid parting lines on critical feature Place injection gates and ejection pins where they don t disrupt function or aesthetics Ejection pins location selected to ensure good ejection Sufficient draft angle to allow easy ejection Gate location and molding flow analyzed to ensure complete filling (particularly of narrow protrusions) These are guidelines 26

27 Design for Automated Assembly 27

28 Design for Automated Assembly Objectives: Minimize capital costs Maximize capacity of assembly equipment Maximize reliability / minimize down time ( Overall Equipment Efficiency ) Maximize flexibility Low and high volume assembly Location that sub-systems are assembled Keys to Success: Utilize industry experts 3-way interaction (design group, molding vendor, automation vendor) Critical review of every part 28

29 Design for Automated Assembly Part Attributes that Simplify Automated Assembly: Enables single axis (vertical) assembly Has good lead-ins Contain alignment features Design out misalignment/misplacement/tangling Avoid slower secondary process steps Make parts symmetrical when possible These are guidelines 29

30 Lead-In Features Diskus Mouthpiece Cover Mouthpiece cover pivots on small posts on the top and bottom housing. Mouthpiece cover has small receptacle for pivot posts. Tight fit required in order to prevent mouthpiece cover from falling off. 30

31 Lead-In Features Diskus Mouthpiece Cover Mouthpiece cover pivots on small posts on the top and bottom housing. Mouthpiece cover has small receptacle for pivot posts. Tight fit required in order to prevent mouthpiece cover from falling off. Simple lead in feature on posts allows for simple slide assembly. 31

32 Alignment Features Taper Dose Counter Correct orientation of parts is critical to function Can assemble with dose counter at 121, 61, or 31 Small hole in housing and dose counter wheels added Including simple pin hole feature improve assembly reliability 32

33 Alignment Features Taper Dose Counter Correct orientation of parts is critical to function Can assemble with dose counter at 121, 61, or 31 Small hole in housing and dose counter wheels added Including simple pin hole feature improved assembly reliability Including small flat features allows for self-alignment of parts in bowl feeder reduced capital costs Surface to enable alignment in bowl feeder 33

34 Single Axis Pick and Place Assembly - Diskus Blister Strip Assembly Lower Housing Assembly Final Assembly Labeling and Packaging 34

35 Single Axis Pick and Place Assembly - Diskus Molded parts simple to mold Simple single axis pick & place assembly Snap-fits hold parts in place Subassembly could be readily shipped to another location 35

36 Workshop Outline Who is 3M Drug Delivery Systems? Why DFMSU? Design Controls DFMSU in Early/Late Stage Development Unit Cost Estimating Wrap Up/Discussion 36

37 Unit Cost Estimating: Why? A unit cost estimate: 1. Is a critical input to many business processes: Required for Business Opportunity Assessments and Net Present Value calculations do we have a viable business? 2. Is a valuable tool in device and process design, development and scale-up: Gives clear visibility to cost contributors Allows identification and prioritization of future work 37

38 Unit Cost Estimating: Example 1. Create the unit cost calculation. 2. Interrogate the results. 38

39 Unit Cost Estimating: Create The following unit cost estimate is for illustration purposes only and is not intended to be representative of any commercial product or product in development. 1. Mix drug and lactose E-4 E-6 2. Fill into foil foil strip 3. Assemble into device 39

40 Unit Cost Estimating: Create 1. Mix drug and lactose E-4 E-6 2. Fill into foil foil strip 3. Assemble into device 40

41 Unit Cost Estimating: Create E-4 E-6 41

42 Unit Cost Estimating: Create E-4 E-6 42

43 Unit Cost Estimating: Interrogate Don t ignore the impact of Indirect Cost on the total factory cost of the product. Direct Costs: Can be allocated specifically to a product or batch. Indirect Costs: Are shared by multiple products. 43

44 Unit Cost Estimating: Interrogate Interrogate the variables that affect Mix Material cost. 44

45 Unit Cost Estimating: Interrogate What effect would increasing Mix Yield from 90% to 95% have on Unit Cost? 45

46 Unit Cost Estimating: Interrogate What effect would increasing ALL Yields from 90% to 95% have on Unit Cost? 46

47 Unit Cost Estimating: Interrogate Interrogate the variables that affect Fill Labor cost. 47

48 Unit Cost Estimating: Interrogate What effect would decreasing Fill Cycle Time from 10 sec/cycle to 5 sec/cycle have on Unit Cost? 48

49 Unit Cost Estimating: Benefit Provides direction and prioritization to your device and process development activities. 49

50 Unit Cost Estimating: Quantifying Uncertainty of Inputs Some inputs I understand very clearly: Example: 12 mg of lactose per dose. Some inputs have much more uncertainty: Example: Overall Equipment Efficiency: 75%? 50%? 90%? What do I do? Use Sensitivity Analysis to quantify the impact that the potential range of each input could have on Unit Cost. 50

51 Unit Cost Estimating: Sensitivity Analysis 51

52 Unit Cost Estimating: Sensitivity Analysis Sensitivity Analysis: Provides a Unit Cost estimate in the form of distribution, not just a single value. Gives visibility to those factors that have the largest contribution to that variability. 52

53 Unit Cost Estimating: Conclusion Provides development direction to shift the mean and reduce variability (risk). Is a valuable tool in DFMSU. 53

54 Workshop Outline Who is 3M Drug Delivery Systems? Why DFMSU? Design Controls DFMSU in Early/Late Stage Development Unit Cost Estimating Wrap Up/Discussion 54

55 DPI Products: Design for Manufacturability and Scale-up (DFMSU) Key Takeaways: Take advantage of Design Control disciplines starting with a detailed specification documents Prove critical processes early in development Leverage industry experts early Know your unit cost and let it support development planning. 55

56 DPI Products: Design for Manufacturability and Scale-up (DFMSU) This Workshop will discuss considerations to ensure success during the various phases of development of dry powder inhaler (DPI) products. Topics will include: device design and development, the importance of a disciplined design control process, process design and development, unit cost estimating and the importance of an overall development map. Participants will leave with a deepened appreciation of the role that DFMSU plays in the development of DPI products. 56

RDD Europe 2009 Workshop

RDD Europe 2009 Workshop RDD Europe 2009 Workshop 20 May 2009, Lisbon, Portugal This file is a redacted version of the presentation used during the Workshop and is suitable for electronic distribution. An Introduction to Differentiating

More information

Dry Powder Inhaler. Developing an Efficient. 3M Conix DPI. White Paper / Spring Proven Solutions that Enable Your Success

Dry Powder Inhaler. Developing an Efficient. 3M Conix DPI. White Paper / Spring Proven Solutions that Enable Your Success 3M Drug Delivery Systems Developing an Efficient Dry Powder Inhaler 3M Conix DPI White Paper / Spring 2011 Proven Solutions that Enable Your Success Introduction introduction Inhalation drug delivery has

More information

Performance of a Fluticasone Propionate/Salmeterol Xinafoate 3M Taper DPI

Performance of a Fluticasone Propionate/Salmeterol Xinafoate 3M Taper DPI 3M Drug Delivery Systems Performance of a Fluticasone Propionate/Salmeterol Xinafoate 3M Taper DPI Poster Reprint / Spring 2011 John Simons 1, Herbert Chiou 1, Louis Sigtermans 1, Tom Robison 1, Debra

More information

2008 IPAC-RS Conference Doing the Right Thing Science, Quality and Patient Focus

2008 IPAC-RS Conference Doing the Right Thing Science, Quality and Patient Focus 2008 IPAC-RS Conference Doing the Right Thing Science, Quality and Patient Focus Patient Perspective Alpha-1 1 Foundation John W. Walsh Patient Focus Personal perspective Challenges and lessons Importance

More information

Device Change Management for Inhaled Products. Loy Britto, Ph.D. GlaxoSmithKline ISAM Congress Munich 2015

Device Change Management for Inhaled Products. Loy Britto, Ph.D. GlaxoSmithKline ISAM Congress Munich 2015 Device Change Management for Inhaled Products Loy Britto, Ph.D. GlaxoSmithKline ISAM Congress Munich 2015 Topics to be covered Update on ISO/TC 084/WG 15: Guidelines for development of drug products- Quality

More information

040716_ANDI_VENTIS WEBSITE(new) Printout 1. HOME PAGE. Welcome to our world of Dry Powder Inhalers!

040716_ANDI_VENTIS WEBSITE(new) Printout 1. HOME PAGE. Welcome to our world of Dry Powder Inhalers! 1. HOME PAGE Welcome to our world of Dry Powder Inhalers! Andi-Ventis Ltd, established in 2001 is a joint venture between Medochemie Ltd, Cyprus and Miat SpA Italy, founded to carry out the pharmaceutical

More information

Graft Delivery Devices

Graft Delivery Devices Graft Delivery Devices About Graft Delivery Devices Nordson MEDICAL Nordson MEDICAL is your partner in the global life sciences market providing innovative components, devices and custom OEM solutions

More information

Device Design Similarity

Device Design Similarity Device Design Similarity Dave Parkins Director DPI Product Development PQRI Workshop on Demonstrating Bioequivalence of Locally Acting Orally Inhaled Drug Products. Bethesda March 9-10, 2009 Device Similarity

More information

SELECTING A DOSAGE FORM FOR DRUG DELIVERY TO THE LUNGS

SELECTING A DOSAGE FORM FOR DRUG DELIVERY TO THE LUNGS SELECTING A DOSAGE FORM FOR DRUG DELIVERY TO THE LUNGS Poonam Sheth, PharmD, PhD, Research Scientist, Inhalation Matthew T. Marmura, Research Scientist, Inhalation Recipharm is frequently asked to help

More information

Appendix E: Device Technique

Appendix E: Device Technique Adult Asthma Care Guidelines for Nurses: Promoting Control of Asthma Appendix E: Device Technique Medications: Inhalation Devices Adapted with permission from The Lung Association: www.lung.ca/asthma/manage/devices.html

More information

Process Drift and it s Resolution in the Manufacture of Drug Products. MDI s and DPI s Metered Dose Inhalations and Dry Powder Inhalations

Process Drift and it s Resolution in the Manufacture of Drug Products. MDI s and DPI s Metered Dose Inhalations and Dry Powder Inhalations Process Drift and it s Resolution in the Manufacture of Drug Products MDI s and DPI s Metered Dose Inhalations and Dry Powder Inhalations Ed Warner, Merck MMD December 2, 2010 PQRI-FDA Workshop on Process

More information

Appendix M: Device Technique

Appendix M: Device Technique Nursing Care of Dyspnea: The 6th Vital Sign in Individuals with Chronic Obstructive Pulmonary Disease (COPD) Appendix M: Device Technique Medications: Inhalation Devices Medications come in many forms.

More information

The Role of EPAG in Standards and Regulatory Guidance Development

The Role of EPAG in Standards and Regulatory Guidance Development The Role of EPAG in Standards and Regulatory Guidance Development Jolyon P. Mitchell on behalf of EPAG Session 4: The Remit, Activities and Achievements of The European Pharmaceutical Aerosols Group 1

More information

SELECTING A DOSAGE FORM FOR DRUG DELIVERY TO THE LUNGS. Dr. Jay T. Holt, Ph.D., Sr. Director, Inhalation & Analytical

SELECTING A DOSAGE FORM FOR DRUG DELIVERY TO THE LUNGS. Dr. Jay T. Holt, Ph.D., Sr. Director, Inhalation & Analytical SELECTING A DOSAGE FORM FOR DRUG DELIVERY TO THE LUNGS Dr. Jay T. Holt, Ph.D., Sr. Director, Inhalation & Analytical www.cirruspharm.com February 2014 INTRODUCTION Cirrus, a Kemwell company, is frequently

More information

Inhalation devices, proper technique and cleaning

Inhalation devices, proper technique and cleaning Preventing Your Symptoms and Taking Your Medications Inhalation devices, proper technique and cleaning Knowing how to use your medications properly is important because inhaled drugs are meant to get directly

More information

Case Study 1: Pharmaceutical Development of EXUBERA

Case Study 1: Pharmaceutical Development of EXUBERA Case Study 1: Pharmaceutical Development of EXUBERA Nancy Harper, PhD Research Fellow, Parenteral Development Center of Emphasis Pfizer Global R&D IPAC-RS Conference November 2006 1 EXUBERA Insulin human

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE PHARMACEUTICAL QUALITY OF INHALATION AND NASAL PRODUCTS

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE PHARMACEUTICAL QUALITY OF INHALATION AND NASAL PRODUCTS European Medicines Agency Inspections London, 16 February 2005 Doc Ref.: EMEA/CHMP/QWP/49313/2005 corr. COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE PHARMACEUTICAL QUALITY OF

More information

Breezhaler. Open to see clear capsule. How do I use my Breezhaler? Care of my Breezhaler

Breezhaler. Open to see clear capsule. How do I use my Breezhaler? Care of my Breezhaler Breezhaler 3 Pull cap off Press buttons once and release Breathe in rapidly and steadily. Hold. Open. Place capsule in chamber. Close (click). Breathe out 4 Open to see clear capsule. If not all clear

More information

AcUMEDr. Arc Wrist Tower. For Wrist Arthroscopy And Fracture Reduction

AcUMEDr. Arc Wrist Tower. For Wrist Arthroscopy And Fracture Reduction AcUMEDr Arc Wrist Tower For Wrist Arthroscopy And Fracture Reduction Arc Wrist Tower Since 1988, Acumed has been designing solutions to the demanding situations facing orthopaedic surgeons, hospitals and

More information

Partner with the Global Leader in Drug Delivery Systems.

Partner with the Global Leader in Drug Delivery Systems. 3M DRUG DELIVERY SYSTEMS Partner with the Global Leader in Drug Delivery Systems. Hurlingham, Argentina Manufacturing Facility Experts at Commercializing Innovation Drug Delivery Systems: It s in the detail

More information

Partner with the Global Leader in Drug Delivery Systems.

Partner with the Global Leader in Drug Delivery Systems. 3M DRUG DELIVERY SYSTEMS Partner with the Global Leader in Drug Delivery Systems. Hurlingham, Argentina Manufacturing Facility Experts at Commercializing Innovation 3M is a global innovation company that

More information

Anoro Ellipta Patient Handout

Anoro Ellipta Patient Handout Anoro Ellipta Patient Handout 1. OPEN Slide the cover down to expose the mouthpiece. You should hear a click. The counter will count down by 1 number. Do not shake this kind of inhaler. Note: If you open

More information

MODELING AN SMT LINE TO IMPROVE THROUGHPUT

MODELING AN SMT LINE TO IMPROVE THROUGHPUT As originally published in the SMTA Proceedings MODELING AN SMT LINE TO IMPROVE THROUGHPUT Gregory Vance Rockwell Automation, Inc. Mayfield Heights, OH, USA gjvance@ra.rockwell.com Todd Vick Universal

More information

Influence of blender type on the performance of ternary dry powder inhaler formulations

Influence of blender type on the performance of ternary dry powder inhaler formulations Institute of Pharmacy Kiel University Influence of blender type on the performance of ternary dry powder inhaler formulations Mats Hertel Theoretical background Binary formulation: 1 st blending Ternary

More information

Caption: The equipment required for testing Fluticasone Propionate (FP) Inhalation Powder in line with a new product-specific monograph (USP36-NF31).

Caption: The equipment required for testing Fluticasone Propionate (FP) Inhalation Powder in line with a new product-specific monograph (USP36-NF31). Product-specific FDA guidance, and product-specific pharmacopeial monographs, point to the use of test equipment, some of which isn t included in the general USP/Ph. Eur. chapters for orally inhaled products

More information

The Medical Letter. on Drugs and Therapeutics

The Medical Letter. on Drugs and Therapeutics The Medical Letter publications are protected by US and international copyright laws. Forwarding, copying or any other distribution of this material is strictly prohibited. For further information call:

More information

10/18/2012. Penn State University Children s Hospital JODIE STABINSKI CRNP MSN AE-C

10/18/2012. Penn State University Children s Hospital JODIE STABINSKI CRNP MSN AE-C Penn State University Children s Hospital JODIE STABINSKI CRNP MSN AE-C Daily: Long-Term Control Corticosteroids (inhaled and systemic) Long-acting beta 2 -agonists (Serevent, Foradil) Methylxanthines

More information

INTRODUCTION. Asthma Drug Delivery - 1

INTRODUCTION. Asthma Drug Delivery - 1 Asthma Drug Delivery Laboratory Experiment Developed by: Alex Jannini, David Krause, Heather Malino and Kevin Sweeney, Rowan University, Department of Chemical Engineering Edited by: C. Stewart Slater

More information

NEBULIZERS, METERED DOSE INHALERS, AND DRY POWDER INHALERS

NEBULIZERS, METERED DOSE INHALERS, AND DRY POWDER INHALERS NEBULIZERS, METERED DOSE INHALERS, AND DRY POWDER INHALERS Douglas S. Gardenhire, Ed.D, RRT-NPS MODULE 1 Manipulate Small Volume Nebulizers by Order or Protocol 1 Objectives for Module 1 At the end of

More information

IPAC-RS/UF Orlando Inhalation Conference March 20, S.T. Horhota 1, C.B. Verkleij 2, P.J.G. Cornelissen 2, L. Bour 3, A. Sharma 3, M.

IPAC-RS/UF Orlando Inhalation Conference March 20, S.T. Horhota 1, C.B. Verkleij 2, P.J.G. Cornelissen 2, L. Bour 3, A. Sharma 3, M. IPAC-RS/UF Orlando Inhalation Conference March 20, 2014 Case Study: Pharmacokinetics and Pharmacodynamics of Tiotropium and Salmeterol Following Parallel Administration in COPD Patients Using Different

More information

Partner with the Global Leader in Drug Delivery Systems

Partner with the Global Leader in Drug Delivery Systems 3M DRUG DELIVERY SYSTEMS Partner with the Global Leader in Drug Delivery Systems Loughborough, United Kingdom Manufacturing Facility Experts at Commercializing Innovation 3M: Transforming New Ideas into

More information

INTEGRATED DESIGN SPACE TO DEVELOP BETTER DPI FORMULATIONS

INTEGRATED DESIGN SPACE TO DEVELOP BETTER DPI FORMULATIONS INTEGRATED DESIGN SPACE TO DEVELOP BETTER DPI FORMULATIONS Here, Filipa Maia, PhD, and Maria Palha, MSc, both Scientists at Hovione, report a study whose objective was to establish relationships between

More information

Everything for Inhalation

Everything for Inhalation Everything for Inhalation Everything for Inhalation Inhalation drug product development at Hovione has a strong focus on formulation for Dry Powder Inhalers (DPI), particularly for capsule-based and reservoir-based

More information

IVIVC in Pediatric OIPs

IVIVC in Pediatric OIPs IPAC-RS/UF Orlando Conference 2014 March 20, 2014 IVIVC in Pediatric OIPs Herbert Wachtel Declaration of Conflicts of Interest H. Wachtel is employee of Boehringer Ingelheim Pharma GmbH & Co. KG, Germany.

More information

ADVANCIA : A TRUE PLATFORM & INNOVATIVE SYSTEM OFFERING EFFICIENT NASAL DOSE DELIVERY

ADVANCIA : A TRUE PLATFORM & INNOVATIVE SYSTEM OFFERING EFFICIENT NASAL DOSE DELIVERY ADVANCIA : A TRUE PLATFORM & INNOVATIVE SYSTEM OFFERING EFFICIENT NASAL DOSE DELIVERY Millions of people suffering from allergic rhinitis use nasal sprays manufactured by Nemera every day. In this article,

More information

Development of a Dry Powder Multi-dose Inhaler using Computational Modeling

Development of a Dry Powder Multi-dose Inhaler using Computational Modeling ENGINEER - Vol. XXXXII, No. 03, pp. [57-65], 2009 The Institution of Engineers, Sri Lanka Development of a Dry Powder Multi-dose Inhaler using Computational Modeling M.A.D.A.Sudeera, V.P.C.Dassanayake,

More information

LubriTose Mannitol Michael Crowley, Director of R&D, Excipients

LubriTose Mannitol Michael Crowley, Director of R&D, Excipients LubriTose Mannitol Michael Crowley, Director of R&D, Excipients Introduction Michael Crowley Director of R&D Excipients 158 St. Highway 320 Norwich, NY 13815 PH 315-802-5970 Michael.Crowley@Kerry.com 2

More information

Lance Listening to End-Users Clinical Use Design Validation Study

Lance Listening to End-Users Clinical Use Design Validation Study Lancing Devices Lance Listening to End-Users Clinical Use Design Validation Study Abstract +clinical + use study (CUS) conducted to validate new babylance design was meeting end-user expectations +prefaced

More information

Assessing Quality of Inhaled Products And Links to Efficacy and Safety

Assessing Quality of Inhaled Products And Links to Efficacy and Safety Assessing Quality of Inhaled Products And Links to Efficacy and Safety Prasad Peri, PhD ONDQA 2011 IPAC-RS Conference Bringing Value To The Patient In A Changing World March 30, 2011 1 Outline of the Presentation

More information

National Transition Strategy to Replace CFC-based. MDIs with in the Commonwealth of Independent States. Paul Krajnik UNIDO, Montreal Protocol Branch

National Transition Strategy to Replace CFC-based. MDIs with in the Commonwealth of Independent States. Paul Krajnik UNIDO, Montreal Protocol Branch National Transition Strategy to Replace CFC-based MDIs with HFA-MDIs in the Commonwealth of Independent States Paul Krajnik UNIDO, Montreal Protocol Branch 1 Starting point: total CFC phase-out CFC phase-out

More information

Gaps In Successful EHR Implementations: The Challenges & Successes Of Providers In The Marketplace

Gaps In Successful EHR Implementations: The Challenges & Successes Of Providers In The Marketplace Gaps In Successful EHR Implementations: The Challenges & Successes Of Providers In The Marketplace A White Paper By Credible Behavioral Health, Inc. October 2016 Contents I. Introduction... 3 Ii. Findings

More information

International Pharmaceutical Aerosol Consortium on Regulation and Science

International Pharmaceutical Aerosol Consortium on Regulation and Science International Pharmaceutical Aerosol Consortium on Regulation and Science 1500 K Street NW Washington DC 20005 Telephone +1 202 230 5607 Fax +1 202 842 8465 Email info@ipacrs.org Web www.ipacrs.org Submitted

More information

University of Groningen. Optimisation of dry powder inhalation Boer, Anne Haaije de

University of Groningen. Optimisation of dry powder inhalation Boer, Anne Haaije de University of Groningen Optimisation of dry powder inhalation Boer, Anne Haaije de IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please

More information

Sub-components in Nicotine cessation products?

Sub-components in Nicotine cessation products? Sub-components in Nicotine cessation products? Mr Arun Sarda, Director of Quality and Regulatory Affairs Member of the HEITKAMP & THUMANN GROUP Regulatory approval of sub-components in nicotine cessation

More information

SMARTPILOT FOR YPSOMATE: TRANSFORMING A PROVEN AUTOINJECTOR INTO A FULLY CONNECTED DEVICE

SMARTPILOT FOR YPSOMATE: TRANSFORMING A PROVEN AUTOINJECTOR INTO A FULLY CONNECTED DEVICE SMARTPILOT FOR YPSOMATE: TRANSFORMING A PROVEN AUTOINJECTOR INTO A FULLY CONNECTED DEVICE In this article, Orfeo Niedermann, Business Development Director, Ypsomed Delivery Systems, provides insights into

More information

Product Specifications and Usage Information P4405, P4410, & P4420 Genesys 30 Dosimeter Holder System

Product Specifications and Usage Information P4405, P4410, & P4420 Genesys 30 Dosimeter Holder System DESCRIPTION The Thermo Genesys 30 Spectrophotometer (G30) is supplied with specially designed dosimeter holders to fit a variety of dosimeters, including the B3 DoseStix and B3 WINdose dosimeters. The

More information

NebuTech nebulizer from Salter. Striving to be #1 IN PATIENT SATISFACTION. To help you and your patients. easy. breathe

NebuTech nebulizer from Salter. Striving to be #1 IN PATIENT SATISFACTION. To help you and your patients. easy. breathe nebulizer from Salter To help you and your patients breathe easy Striving to be #1 IN PATIENT SATISFACTION nebulizer from Salter Let go to work for you and your patients today. Performance Versatility

More information

HARD TWO-PIECE HPMC CAPSULES FOR PHARMACEUTICAL APPLICATIONS IN INHALATION

HARD TWO-PIECE HPMC CAPSULES FOR PHARMACEUTICAL APPLICATIONS IN INHALATION HARD TWO-PIECE HPMC CAPSULES FOR PHARMACEUTICAL APPLICATIONS IN INHALATION 2 3 QUALICAPS HISTORY Over one hundred years of experience in the manufacturing and filling of hard two-piece capsules Qualicaps

More information

Excipient Considerations for Continuous Manufacturing Implementation

Excipient Considerations for Continuous Manufacturing Implementation Excipient Considerations for Continuous Manufacturing Implementation FDA-PQRI Conference March 22-24, 2017 David R. Schoneker Director of Global Regulatory Affairs Email: dschoneker@colorcon.com 1 Continuous

More information

Pocket Guide to Inhaler Technique A Step-By-Step Guide for Healthcare Professionals

Pocket Guide to Inhaler Technique A Step-By-Step Guide for Healthcare Professionals Pocket Guide to Inhaler Technique A Step-By-Step Guide for Healthcare Professionals Endorsed by NHSGGC Respiratory Managed Clinical Network; June 2016 Designed by Medical Illustration Services Contents

More information

For personal use only. Investor Briefing. Bayswater, 1 st December 2016

For personal use only. Investor Briefing. Bayswater, 1 st December 2016 Investor Briefing Bayswater, 1 st December 2016 Introduction Samantha Cheetham Chief Executive Officer To be an innovative leader in the dental industry, developing our people and partnering with dentists

More information

Boehringer Ingelheim BioXcellence. Producing Value. Global Contract Manufacturing Excellence

Boehringer Ingelheim BioXcellence. Producing Value. Global Contract Manufacturing Excellence Boehringer Ingelheim BioXcellence Producing Value Global Contract Manufacturing Excellence Your World Class Contract Manufacturer Boehringer Ingelheim BioXcellence Producing Value Boehringer Ingelheim

More information

Your Inhaler Devices & You

Your Inhaler Devices & You 1 Your Inhaler Devices & You COUNSEL ON THE APPROPRIATE USE OF A: METERED DOSE INHALER (MDI) DRY POWDER INHALER (DPI) DISCUSS THE APPROPRIATE USAGE OF A PEAK FLOW METER AND SPACER/HOLDING CHAMBER DEVICE

More information

Inhalation Product Research at FDA

Inhalation Product Research at FDA Inhalation Product Research at FDA Changning Guo Ph. D., Chemist Division of Pharmaceutical Analysis FDA/CDER/OPS/OTR 2016 GPhA CMC workshop, May 17, 2016 Disclaimer: This presentation reflects the views

More information

GMMMG Asthma Formulary Inhaler Options August 2017

GMMMG Asthma Formulary Inhaler Options August 2017 Regular Preventer Beclometasone Beclometasone Beclometasone Brand name Qvar Easi-Breathe Clenil Modulite Easyhaler Device MDI MDI DPI Strengths 50 microgram 100 microgram 200 microgram Adult asthma 2 inhalations

More information

IROC Liver Phantom. Guidelines for Planning and Irradiating the IROC Liver Phantom. Revised July 2015

IROC Liver Phantom. Guidelines for Planning and Irradiating the IROC Liver Phantom. Revised July 2015 IROC Liver Phantom Guidelines for Planning and Irradiating the IROC Liver Phantom. Revised July 2015 The study groups are requests that each institution keep the phantom for no more than 2 weeks. During

More information

Lava. Chairside Oral Scanner C.O.S. The Future in Motion

Lava. Chairside Oral Scanner C.O.S. The Future in Motion Lava Chairside Oral Scanner C.O.S. The Future in Motion A Brilliant Impression of the Future. What if you could instantaneously view impressions in awe-inspiring detail and turn an unpleasant procedure

More information

A NEW, ADVANCED HIGH- THROUGHPUT SYSTEM FOR AUTOMATED INHALER TESTING

A NEW, ADVANCED HIGH- THROUGHPUT SYSTEM FOR AUTOMATED INHALER TESTING A NEW, ADVANCED HIGH- THROUGHPUT SYSTEM FOR AUTOMATED INHALER TESTING Two years ago, Novi Systems Ltd set out to shake up the inhaler automation market. On December 8th, 2015, at the Drug Delivery to the

More information

Capturing lightning In A Bottle

Capturing lightning In A Bottle Capturing lightning In A Bottle Featured In: Manufacturing & Capabilities I Facility of the Year I ISPE By Stephen Hall, Senior Director, Engineering, MannKind Corporation; Juergen Martens, Chief Technical

More information

COMPARISON OF THE RESPIRABLE FRACTION FROM THREE DIFERENT DPI DEVICES

COMPARISON OF THE RESPIRABLE FRACTION FROM THREE DIFERENT DPI DEVICES COMPARISON OF THE RESPIRABLE FRACTION FROM THREE DIFERENT DPI DEVICES Miriam Sanz Cermeño and Helena Maria Cabral Marques UCTF, Faculdade de Farmácia, Universidade de Lisboa, PORTUGAL 1. Introduction Inhalation

More information

How can I benefit most from my COPD medications?

How can I benefit most from my COPD medications? Fact Sheet: COPD Medications and Delivery Devices How can I benefit most from my COPD medications? COPD medications can improve your symptoms. By taking the right medication at the right time, you can

More information

SINCE 1978 MADE IN THE USA PRO 7000 SERIES SUPPLEMENTARY MACHINES MEDICAL SERIES. engineered for success

SINCE 1978 MADE IN THE USA PRO 7000 SERIES SUPPLEMENTARY MACHINES MEDICAL SERIES. engineered for success SINCE 1978 MADE IN THE USA 1 TM PRO 7000 SERIES SUPPLEMENTARY MACHINES MEDICAL SERIES ENGINEERED FOR SPORTS PERFORMANCE MAGNUM S PRO 7000 SERIES Thirty years of industry experience, innovation, and customer

More information

Quantos Powder Dosing Automated Powder Dosing Unmatched accuracy Assured user safety Increased efficiency

Quantos Powder Dosing Automated Powder Dosing Unmatched accuracy Assured user safety Increased efficiency Quantos Powder Dosing Automated Powder Dosing Unmatched accuracy Assured user safety Increased efficiency Simplified Powder Dosing for Maximum Accuracy and Safety The Powder Challenge The Powder Challenge

More information

ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE

ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE CATALYSTS DRIVING SUCCESSFUL DECISIONS IN LIFE SCIENCES ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE AT KANTAR HEALTH, ONCOLOGY

More information

COPD Device Workshop. Summary. Role of inhaler device in COPD. Why use inhaler device in COPD?

COPD Device Workshop. Summary. Role of inhaler device in COPD. Why use inhaler device in COPD? Part 1 Role of inhaler device in COPD COPD Device Workshop Dr Philip Lee Respiratory and Sleep Physician St George Hospital, Sydney Part 2 Part 3 Part 4 Incorrect inhaler technique-adverse clinical outcomes

More information

Understanding cascade impaction and its importance for inhaler testing

Understanding cascade impaction and its importance for inhaler testing Understanding cascade impaction and its importance for inhaler testing Mark Copley, Technical Sales Manager Inhalation product development is an important area of activity for the pharmaceutical sector.

More information

Overview Internal review

Overview Internal review Overview Internal review Presentation title: QRM, It s not all about the assessment Track title: Day 1, Session 2 Speaker: Seamus Orr Date / Time: 10 August 2015, 14.30 15.00 Time allotted: 30 minutes

More information

Product Guide. MSP Corporation Rice Creek Parkway, Suite 300. Shoreview, Minnesota 55126, U.S.A. Phone: Fax:

Product Guide. MSP Corporation Rice Creek Parkway, Suite 300. Shoreview, Minnesota 55126, U.S.A. Phone: Fax: Product Guide inhalertesting MSP Corporation 5910 Rice Creek Parkway, Suite 300 Shoreview, Minnesota 55126, U.S.A. Phone: 651.287.8100 Fax: 651.287.8140 sales@mspcorp.com www.mspcorp.com About This Guide

More information

Thermo Scientific ART Pipette Tips. superior tips. for any application, any pipette

Thermo Scientific ART Pipette Tips. superior tips. for any application, any pipette Thermo Scientific ART Pipette Tips superior tips for any application, any pipette How do we make it easy to select exceptional tips for all the pipette brands you use? It's ART. The Thermo Scientific ART

More information

8 Performing Medical Procedures

8 Performing Medical Procedures 8 The Terason usmart3200t Ultrasound System can aid in performing medical procedures such as biopsies. Depending on whether you purchased the additional equipment required for these procedures, you may

More information

Current Challenges and Opportunities in Demonstrating Bioequivalence

Current Challenges and Opportunities in Demonstrating Bioequivalence Current Challenges and Opportunities in Demonstrating Bioequivalence Gur Jai Pal Singh, Ph.D. Watson Laboratories, Inc. Corona, California, USA Demonstrating Bioequivalence of Locally Acting Orally Inhaled

More information

WE VE MADE FIXED FULL-ARCH RESTORATIONS A SNAP. NO SCREWS. NO CEMENT. NO COMPROMISES.

WE VE MADE FIXED FULL-ARCH RESTORATIONS A SNAP. NO SCREWS. NO CEMENT. NO COMPROMISES. WE VE MADE FIXED FULL-ARCH RESTORATIONS A SNAP. NO SCREWS. NO CEMENT. NO COMPROMISES. LOCATOR F-Tx A NEW WAY TO THINK ABOUT FIXED FULL-ARCH RESTORATIONS. LOCATOR F-Tx IS A SIMPLIFIED, TIME SAVING SOLUTION

More information

TRAINING DEVICE OPPORTUNITIES AND SOLUTIONS FOR A CHANGING RESPIRATORY MARKET

TRAINING DEVICE OPPORTUNITIES AND SOLUTIONS FOR A CHANGING RESPIRATORY MARKET TRAINING DEVICE OPPORTUNITIES AND SOLUTIONS FOR A CHANGING RESPIRATORY MARKET Building on his previous articles in ONdrugDelivery on training devices and drug delivery device education, here, Joe Reynolds,

More information

COMMENTS. Submitted by The International Pharmaceutical Aerosol Consortium

COMMENTS. Submitted by The International Pharmaceutical Aerosol Consortium COMMENTS on a draft Guidance for Industry Nasal Spray and Inhalation Solution, Suspension, and Spray Drug Products Chemistry, Manufacturing, and Controls Documentation (Docket No. 99D-1454) Submitted by

More information

ISO INTERNATIONAL STANDARD. Dentistry Reversible-irreversible hydrocolloid impression material systems

ISO INTERNATIONAL STANDARD. Dentistry Reversible-irreversible hydrocolloid impression material systems INTERNATIONAL STANDARD ISO 13716 First edition 1999-05-01 Dentistry Reversible-irreversible hydrocolloid impression material systems Art dentaire Systèmes de produits pour empreintes à base d'hydrocolloïdes

More information

Summary of ACEA Tests. ACEA Comments

Summary of ACEA Tests. ACEA Comments 8 th TEG FlexPLI Meeting on 19.05.2009 Offices of TÜV Rheinland, Cologne Summary of ACEA Tests ACEA Comments Page 1 Content: ACEA previous and latest test series Problems related to Flex-GTα and Flex-GTR

More information

OPTIMISING ANALYTICAL STRATEGIES FOR THE DEMONSTRATION OF BIOEQUIVALENCE IN A GENERIC NEBULISER

OPTIMISING ANALYTICAL STRATEGIES FOR THE DEMONSTRATION OF BIOEQUIVALENCE IN A GENERIC NEBULISER OPTIMISING ANALYTICAL STRATEGIES FOR THE DEMONSTRATION OF BIOEQUIVALENCE IN A GENERIC NEBULISER US FDA guidance for the in vitro demonstration of bioequivalence in a generic nebuliser directly references

More information

15 cm Reservoir Tubing. 210 cm Tubing

15 cm Reservoir Tubing. 210 cm Tubing 12 Aerosol Therapy nebulisers AEROSOL THERAPY MICRO MIST SMALL VOLUME NEBULISER The MICRO MIST small volume nebuliser is designed for performance and economy and can be used for hand-held or in-line treatments.

More information

MDI Bonanza. Dwayne Griffin, DO

MDI Bonanza. Dwayne Griffin, DO MDI Bonanza Dwayne Griffin, DO Bonanza 3. A MDI costing $200 - $500 per month SISYPHUS MDI Griffin Mountain Evolution of Deliver Systems for COPD in the US 2003 2009 2011 2013 2004 2012 2014 Prescribing

More information

The Use of Physics-Based Modeling to Better Design Drug- Device Interface. Yoen-Ju Son, PhD Merck Research Laboratory, Summit, NJ

The Use of Physics-Based Modeling to Better Design Drug- Device Interface. Yoen-Ju Son, PhD Merck Research Laboratory, Summit, NJ The Use of Physics-Based Modeling to Better Design Drug- Device Interface Yoen-Ju Son, PhD Merck Research Laboratory, Summit, NJ Presentation Outline Physics-based modeling in pharmaceutical industry Pulmonary

More information

RPC Liver Phantom Highly Conformal Stereotactic Body Radiation Therapy

RPC Liver Phantom Highly Conformal Stereotactic Body Radiation Therapy RPC Liver Phantom Highly Conformal Stereotactic Body Radiation Therapy Guidelines for Planning and Irradiating the RPC Liver Phantom. Revised Dec 2005 Credentialing for this protocol requires four steps:

More information

NOVA SELECTORIZED SINGLE AND DUAL STATIONS

NOVA SELECTORIZED SINGLE AND DUAL STATIONS NOVA SELECTORIZED SINGLE AND DUAL STATIONS 4 key features of nautilus nova equipment Increased visibility through transparent weight towers. Integrated 5 lb. increment add-on weight system inside fully-shielded

More information

University of Groningen. Technology in practice Lexmond, Anne

University of Groningen. Technology in practice Lexmond, Anne University of Groningen Technology in practice Lexmond, Anne IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document

More information

Inhaler technique reminder cards

Inhaler technique reminder cards Inhaler technique reminder cards Produced by the Medicines Optimisation Team NHS NEW Devon CCG For further information visit: www.newdevonccg.nhs.uk/information-for-patients/medicines-and-treatments/100073

More information

MAKE THE CLEAR CHOICE. IV Products and Accessories Designed to Help Maximize Clinical Performance While Optimizing Savings

MAKE THE CLEAR CHOICE. IV Products and Accessories Designed to Help Maximize Clinical Performance While Optimizing Savings MAKE THE CLEAR CHOICE. IV Products and Accessories Designed to Help Maximize Clinical Performance While Optimizing Savings EXCEPTIONAL QUALITY, PERFORMANCE AND VALUE. Infuse medications and fluids accurately

More information

Dräger Alcotest 6820 Alcohol Screening Device

Dräger Alcotest 6820 Alcohol Screening Device Dräger Alcotest 6820 Alcohol Screening Device Dräger Alcotest 6820 is the logical successor to the successful Alcotest 6810. The compact hand-held measuring instrument Alcotest is quickly ready for use

More information

Beclometasone dipropionate (BDP) Prophylactic management of mild, moderate or severe asthma in adults

Beclometasone dipropionate (BDP) Prophylactic management of mild, moderate or severe asthma in adults CLENIL MODULITE Beclometasone dipropionate (BDP) Prophylactic management of mild, moderate or severe asthma in adults Corticosteroids for the treatment of chronic asthma in adults and children aged 12

More information

HUMAN FACTORS ENGINEERING OF SELF-INJECTION DEVICES

HUMAN FACTORS ENGINEERING OF SELF-INJECTION DEVICES HUMAN FACTORS ENGINEERING OF SELF-INJECTION DEVICES In this overview, Tobias Nemeth, Business Development Manager, Ypsomed Delivery Systems, provides a useful insight into human factors engineering. The

More information

IROC Lung Phantom 3D CRT / IMRT. Guidelines for Planning and Irradiating the IROC Lung Phantom. Revised Dec 2015

IROC Lung Phantom 3D CRT / IMRT. Guidelines for Planning and Irradiating the IROC Lung Phantom. Revised Dec 2015 IROC Lung Phantom 3D CRT / IMRT Guidelines for Planning and Irradiating the IROC Lung Phantom. Revised Dec 2015 The IROC requests that each institution keep the phantom for no more than 2 weeks. During

More information

Your Partner in Healing

Your Partner in Healing Your Partner in Healing Euromed provides all functions necessary for market-ready hydrocolloid wound dressings. With fully integrated services, Euromed is one of a select few custom hydrocolloid manufacturers

More information

Public Assessment Report Scientific discussion. Flumetor (salmeterol xinafoate/fluticasone propionate) SE/H/1068/01-02/DC

Public Assessment Report Scientific discussion. Flumetor (salmeterol xinafoate/fluticasone propionate) SE/H/1068/01-02/DC Public Assessment Report Scientific discussion Flumetor (salmeterol xinafoate/fluticasone propionate) SE/H/1068/01-02/DC This module reflects the scientific discussion for the approval of Flumetor. The

More information

Year in review. Vit Perlik Director of Regulatory Science and Clinical Development

Year in review. Vit Perlik Director of Regulatory Science and Clinical Development Year in review Vit Perlik Director of Regulatory Science and Clinical Development Content Year in review Covering September 2013 to September 2014 Where the regulation goes selection of events for illustration

More information

The Montreal Protocol and the Phase-out of CFC-based Metered Dose Inhalers. Paul Krajnik UNIDO, Montreal Protocol Branch

The Montreal Protocol and the Phase-out of CFC-based Metered Dose Inhalers. Paul Krajnik UNIDO, Montreal Protocol Branch The Montreal Protocol and the Phase-out of CFC-based Metered Dose Inhalers Paul Krajnik UNIDO, Montreal Protocol Branch 1 The Montreal Protocol Binding international agreement for the preservation and

More information

The influence of lactose particle size on dry powder inhalation performance

The influence of lactose particle size on dry powder inhalation performance The influence of lactose particle size on dry powder inhalation performance MCC Starch Lactose Inhalation Superdisintegrants 1 Introduction In most dry powder inhalation (DPI) formulations carriers are

More information

Guide to Inhaled Treatment Choices

Guide to Inhaled Treatment Choices Guide to Inhaled Treatment Choices Note: this is guidance only, it is important to consider which device is best suited to the patient. This may NOT be the first line choice (but should be on the joint

More information

UK X-FEL National Laboratory Perspective

UK X-FEL National Laboratory Perspective UK X-FEL National Laboratory Perspective Susan Smith STFC ASTeC IoP PAB/STFC Workshop Towards a UK XFEL 16 th February 2016 Content Overview STFC national labs capabilities FEL R&D Underpinning accelerator

More information

Guide to Inhaled Treatment Choices

Guide to Inhaled Treatment Choices Guide to Inhaled Treatment Choices Note: this is guidance only, it is important to consider which device is best suited to the patient. This may NOT be the first line choice (but should be on the joint

More information

Chapter 1 Quiz. Name: 1. List six characteristics of today s manufacturing environment.

Chapter 1 Quiz. Name: 1. List six characteristics of today s manufacturing environment. Chapter 1 Quiz Name: 1. List six characteristics of today s manufacturing environment. 2. What are the four steps that products go through from raw material and components to finished products as discussed

More information

EPAG Perspective - Regulatory Advances Related to Nasal Spray Pumps. Dr G.Williams Nasal Drug Delivery Management Forum London, 15 Apr 2010

EPAG Perspective - Regulatory Advances Related to Nasal Spray Pumps. Dr G.Williams Nasal Drug Delivery Management Forum London, 15 Apr 2010 1 EPAG Perspective - Regulatory Advances Related to Nasal Spray Pumps Dr G.Williams Nasal Drug Delivery Management Forum London, 15 Apr 2010 Overview 2 EPAG, what is it?, background, this project Regulatory

More information